AIMMAX THERAPEUTICS INC
Novel Anti-Infectives and Anti-Inflammatories
DURHAM, United States · Founded 2022
- Headquarters
- DURHAM, North Carolina
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- aimmaxrx.com
- Last Round
- GrantApr 2025
- Rounds
- 4
About
AimMax Therapeutics is a biopharmaceutical company focused on discovery and development of novel anti-infective and anti-inflammatory therapies. The company's pipeline includes treatments targeting resistant bacteria, fungi, and other microorganisms, as well as an ophthalmic corticosteroid formulation that received FDA NDA approval in March 2024.
Summary
AIMMAX THERAPEUTICS INC is a Biotech company based in DURHAM, United States, founded in 2022. Its most recent funding was a Grant round in Apr 2025. Investors include Department of Health and Human Services.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.